伊諾維奧製藥 INO 深 滬
已收盤 08-07 16:00:00 美东时间
0.668
-0.006
-0.86%
華盛通- 最 高0.6845
- 今 開0.6732
- 成交量 305.11万股
- 最 低 0.641
- 昨 收 0.6738
- 總市值 6902.17万
- 52周最高 2.9789
- 市盈率 靜 --
- 換手率 2.95%
- 52周最低 0.5632
- 委 比 -76.92%
- 總股本 1.03亿
- 歷史最高 405.48
- 量 比 0.54
- 振 幅 6.46%
- 歷史最低 0.5632
- 每 手 1
- 風險率 0.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Piper Sandler Reiterates Overweight on Inovio Pharmaceuticals, Lowers Price Target to $4
Piper Sandler analyst Edward Tenthoff reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight and lowers the price target from $6 to $4.
08-04 00:00
Inovio Pharmaceuticals Announces New Equity Financing Agreement
Inovio Pharmaceuticals ( ($INO) ) has shared an announcement. On July 29, 2026,...
07-31 19:48
Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Shares of Microsoft Corp (NASDAQ:MSFT) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results. Microsoft reported fourth-quarter revenue of $90.01 billion, up 18% year-over-year. The revenue total beat a Street consensus estimate of $87.62...
07-30 16:30
Inovio Stock Falls 21% After Hours: Here's What's Going On
Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares tumbled in Wednesday’s after-hours session after the biotechnology company priced a $20 million underwritten public offering of common stock and accompanying warrants. The stock closed Wednesday’s regular session up 0.97% at $1.04 before falling 21.20%...
07-30 14:31
Inovio slumps 22% on pricing $20M stock offering
Inovio Pharmaceuticals (INO) priced an underwritten public offering expected to raise ~$20M in gross proceeds. The offering consists of 21.05M common shares and accompanying warrants to purchase up to...
07-30 12:37
INOVIO Pharmaceuticals Announces Proposed Public Offering Of Shares And Warrants
INOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it intends to offer and sell shares of its common stock and acc...
07-30 04:04
Inovio Pharmaceuticals May Offer Up To $300 Mln Of Securities
Inovio Pharmaceuticals May Offer Up To $300 Mln Of Securities
07-03 04:09
美股大行评级 | 瑞杰金融上调美光目标价从530美元升至1100美元；AMD、Arm、戴尔、英特尔等获多家机构上调目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13.5美元升至14美元；BTIG：维持Jade Biosciences"买入"评级，目标价从39美元升至74美元
06-02 16:25
HC Wainwright & Co. Maintains Neutral on Inovio Pharmaceuticals, Lowers Price Target to $2.5
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Neutral and lowers the price target from $3 to $2.5.
06-01 19:00
